Daré Bioscience, Inc.
DARE
$2.04
-$0.04-1.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -183.46% | 139.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -183.46% | 139.94% | |||
| Cost of Revenue | -- | -83.85% | |||
| Gross Profit | 99.07% | 84.10% | |||
| SG&A Expenses | 2.98% | 15.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.36% | -13.49% | |||
| Operating Income | 16.44% | 14.98% | |||
| Income Before Tax | 8.26% | 20.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.26% | 20.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.26% | 20.49% | |||
| EBIT | 16.44% | 14.98% | |||
| EBITDA | 23.86% | 17.82% | |||
| EPS Basic | 9.42% | 27.19% | |||
| Normalized Basic EPS | 9.41% | 34.36% | |||
| EPS Diluted | 9.42% | 27.51% | |||
| Normalized Diluted EPS | 9.41% | 34.36% | |||
| Average Basic Shares Outstanding | 1.28% | 9.23% | |||
| Average Diluted Shares Outstanding | 1.28% | 9.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||